HIV Home
About HIV
Benchmrk
About Enrolling
Benchmrk-IT
About Enrolling
Benchmrk-ExPI
About Enrolling
Expanded Access Research Program
En español
About this Study
Condition
Intervention
Phase
Human Immunodeficiency Virus
Drug: MK-0518
Phase III
BENCHMRK
You may be eligible for the study if you are:
HIV positive with viral load greater than 1,000.
Have failed certain types of antiretroviral therapy.
On the same antiretroviral therapy for at least the past two months.
Are 16 years or older.
Participation in this 1-year study includes at no cost:
Regular doctor visits
Investigational study drug or placebo
Laboratory testing
Copyright © 2005-2007 Merck & Co., Inc., All rights reserved.
